Skip to main content

Reporter Feb 9 2018

A new target for neuroblastoma

Feb. 14, 2018—Vanderbilt investigators have discovered that a sirtuin protein has oncogenic properties in neuroblastoma cells — and that blocking it reduces their growth and tumor-like characteristics.

Read more


Cognition in rare hormonal disorder

Feb. 13, 2018—Vanderbilt investigators have conducted the first systematic evaluation of cognitive function in children with a rare genetic disorder.

Read more


Protecting transplanted lungs

Feb. 12, 2018—Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered.

Read more


Muscular dystrophy clue

Feb. 9, 2018—Vanderbilt investigators have discovered a role for immune system T cells in slowing the decline in skeletal muscle function in patients with Duchenne muscular dystrophy.

Read more


Bone and Joint Franklin thrives on team approach

Feb. 8, 2018—Spine surgeon Byron Stephens, MD, works closely with physiatrists who treat patients with nonsurgical options at Vanderbilt Bone and Joint Franklin.

Read more


Neurosurgery, spine programs named among best in nation

Feb. 8, 2018—Becker’s Hospital Review has recognized Vanderbilt University Medical Center (VUMC) as having one of the 100 best neurosurgery and spine programs in the nation.

Read more


Neurology’s Davis blends modesty, clinical excellence

Feb. 8, 2018—Thomas “Tom” Davis, MD, enjoys archery when he’s not treating people with movement disorders.

Read more


Gift supports addiction medicine training program

Feb. 8, 2018—The 2016 Surgeon General’s Report on Alcohol, Drugs and Health, “Facing Addiction in America,” leaves little question about the growing problem of addiction.

Read more


Event showcases REDCap’s data management versatility

Feb. 8, 2018—Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.

Read more


Study seeks to boost breast tumor immune response

Feb. 8, 2018—Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.

Read more


Study helps map signaling system in brain linked to ASD

Feb. 8, 2018—Researchers at Vanderbilt University have worked out part of the “wiring diagram” of a signaling system in the brain that has been linked to autism spectrum disorder (ASD).

Read more


AIDS-defining events increase mortality risk: study

Feb. 8, 2018—When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more